China Digest: UK firm buys hotel from CIMC; Taiwania Capital joins Regenacy round

Hilton hotel at Bristol Airport

UK property developer The Ability Group acquired Hampton by Hilton hotel at Bristol Airport from a Chinese investment vehicle while Regenacy Pharmaceuticals has raised $30 million in a Series A round of financing jointly led by Cobro Ventures and Taiwania Capital. 

UK-based  Ability buys Bristol hotel from Chinese CIMC Capital

UK property developer The Ability Group has acquired Hampton by Hilton hotel at Bristol Airport for £24 million ($29 million), according to reports in local media. 

Ability bought the hotel from CIMC Capital, an investment vehicle of Chinese state-owned logistics and energy equipment supplier China International Marine Containers (Group) Ltd (CIMC). 

CIMC’s partnership with the 201-bedroom hotel started in 2015. The hotel was financed and owned by CIMC, while Hilton Worldwide managed it.

CBRE acted as an adviser for the deal. 

Taiwania Capital co-leads $30m Series A round in Regenacy

US-based Regenacy Pharmaceuticals has raised $30 million in a Series A round of financing jointly led by US private investment firm Cobro Ventures and Taipei & Silicon Valley headquartered Taiwania Capital Management Corporation, according to a company statement. 

Chinese healthcare focused venture capital firm 3E Bioventures Capital, Shanghai-based Yonghua Capital’s sister firm Yonjin Capital, drug discovery platform Viva Biotech Holdings and Ta ya Venture Holdings Limited have also participated in the current round. The other individual investors are undisclosed.  

As part of the deal, Regenacy offered three seats on its board of directors to the investors. 

The clinical-stage focused Regenacy was set up in 2016 following the acquisition of small molecule drugs company Acetylon Pharmaceuticals by the global drug developer Celgene. Regenacy is engaged in developing novel treatments for diabetes and peripheral neuropathies. 

Proceeds will be used to facilitate a Phase 2 proof-of-concept trial for ricolinostat, an oral, selective histone deacetylase 6 (HDAC6) inhibitor, in diabetic peripheral neuropathy (DPN).

Established in 2017 by National Development Fund of the Executive Yuan of Taiwan and other investors, Taiwania Capital has focused on early-stage companies. It has launched two funds with a total size of $350 million. 

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.